Preventing Postpartum Hemorrhage After Cesarean Delivery: A Network Meta-Analysis of Available Pharmacologic Agents
Authors:
- 21 November 2022
- journal article
- review article
- Published by Wolters Kluwer Health in Obstetric Anesthesia Digest
- Vol. 42 (4) , 164-165
Abstract
(Am J Obstet Gynecol. 2022;226:347–365) Postpartum hemorrhage (PPH) is a leading cause of maternity mortality. Cesarean deliveries (CDs) put women at an increased risk of PPH. The World Health Organization (WHO) suggests oxytocin be administered to women to mitigate the risk of PPH without regards to type of delivery or whether CD was prepartum or intrapartum. This study aimed to use network meta-analysis (NMA) to determine whether prophylactic agent efficacy is influenced by surgical context for parturients undergoing CD.Keywords
This publication has 4 references indexed in Scilit:
- International consensus statement on the use of uterotonic agents during caesarean sectionAnaesthesia, 2019
- A Randomized, Double-blinded Trial of a “Rule of Threes” Algorithm versus Continuous Infusion of Oxytocin during Elective Cesarean DeliveryAnesthesiology, 2015
- Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose, part 2Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 2013
- Effect of carbetocin, a long-acting oxytocin analog on the postpartum uterusClinical Pharmacology & Therapeutics, 1992